CCEP monthly performance report
Monthly CCEP research: returns, drawdown, relative strength, seasonality, and key stats.
CCEP monthly report
—
Key takeaways
- Coca-Cola Europacific Partners (CCEP) closed September 2026 at $102.77, down 4.86% for the month and +14.11% over the trailing 12 months.
- Year-to-date, CCEP is +13.31%, outperforming the S&P 500 which has returned +12.08% YTD.
- The stock is trading +5.32% versus its 200-day moving average ($97.58), a bullish technical signal.
- Over the past three years, CCEP has underperformed the S&P 500 by −5.68%, with a relative strength index reading of 96.7.
- Win rate over the trailing 39 months stands at 61.5% — 24 positive months versus 15 negative months.
Coca-Cola Europacific Partners ended September 2026 at $102.77, posting a monthly return of −4.86%. The S&P 500 returned −0.36% over the same window, leaving relative performance at −4.50%.
The current quarter stands at +2.70% (Q3 2026 (QTD)), while medium-term trend remains constructive: price is +5.32% versus the 200-day moving average ($97.58).
Year-to-date, CCEP is +13.31% against SPY +12.08%, a gap of +1.23%. The stock is currently −9.57% below its 52-week high, with maximum 3-year drawdown at −19.08%.
| Period | CCEP | S&P 500 (SPY) | Excess return |
|---|---|---|---|
| 1 Day | −0.11% | +0.85% | −0.96% |
| 1 Week | −4.65% | −0.11% | −4.53% |
| 1 Month | −4.86% | −0.36% | −4.50% |
| 3 Months | +11.68% | +5.36% | +6.33% |
| 6 Months | −1.68% | +12.68% | −14.37% |
| YTD | +13.31% | +12.08% | +1.23% |
| 12 Months | +14.11% | +16.22% | −2.11% |
| 3 Years | +64.75% | +70.43% | −5.68% |
| Rank | Month | Return |
|---|---|---|
| #1 | Feb 2026 | +20.43% |
| #2 | Jun 2026 | +10.34% |
| #3 | Dec 2023 | +10.06% |
| #4 | Feb 2025 | +9.82% |
| #5 | Jul 2026 | +9.38% |
| Rank | Month | Return |
|---|---|---|
| #1 | Mar 2026 | −17.89% |
| #2 | Aug 2025 | −8.32% |
| #3 | Oct 2023 | −6.35% |
| #4 | Sep 2026 | −4.86% |
| #5 | May 2026 | −4.10% |
| Quarter | Return |
|---|---|
| Q2 2025 | +6.54% |
| Q3 2025 | −2.49% |
| Q4 2025 | +0.32% |
| Q1 2026 | −0.03% |
| Q2 2026 | +10.37% |
| Q3 2026 (QTD) | +2.70% |
| Year | Return |
|---|---|
| 2023 | +20.64% |
| 2024 | +15.09% |
| 2025 | +18.08% |
| 2026 | +13.31% |
| Metric | Value |
|---|---|
| 52-Week High | $113.64 (2026-07-28) |
| 52-Week Low | $84.66 (2026-01-07) |
| Current Price | $102.77 |
| 200-Day Moving Average | $97.58 |
| Price vs 200DMA | +5.32% |
| 3-Year Maximum Drawdown | −19.08% (2026-05-15) |
| Current Drawdown from 52W High | −9.57% |
| RS metric | Value |
|---|---|
| RS Index (3-year, rebased to 100) | 96.7 |
| 3-Year Excess Return vs S&P 500 | −5.68% |
| RS Peak | 123.8 (Apr 2025) |
| RS Trough | 85 (Jun 2026) |
| Status | Underperforming Benchmark |
Frequently asked questions
What was CCEP's return for this report period?
CCEP returned −4.86% in the latest monthly window ending 2026-09-11.
Has CCEP outperformed SPY year to date?
YTD CCEP: +13.31% vs SPY: +12.08%.
What is CCEP's 12-month return?
+14.11% over the trailing 12 months.
Is CCEP above or below its 200-day moving average?
Price is +5.32% versus 200DMA ($97.58).
What is the maximum drawdown in the 3-year window?
−19.08% on 2026-05-15.